Cell surface-associated mucins in signal transduction

被引:336
作者
Singh, Pankaj K. [1 ]
Hollingsworth, Michael A. [1 ]
机构
[1] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
关键词
D O I
10.1016/j.tcb.2006.07.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mucins are heavily glycosylated high molecular weight glycoproteins, which are involved in the protection and lubrication of luminal epithelial surfaces. Transmembrane mucins also engage in signal transduction, through extracellular domain-mediated ligand binding or by interacting with receptors for growth and differentiation factors. The cytoplasmic tail of MUC1 (MUC1CT), the best characterized of the transmembrane mucins, is involved in several signaling pathways, including those involving Ras, beta-catenin, p120 catenin, p53 and estrogen receptor alpha. MUC1CT also forms complexes with transcription factors, and then translocates to the nucleus by an unknown mechanism, where it is believed to influence the transcription of their target genes. MUC1CT has also been proposed to localize to mitochondrial membranes under conditions of genotoxic stress, where it attenuates the apoptotic pathway in response and confers resistance to apoptosis-inducing drugs.
引用
收藏
页码:467 / 476
页数:10
相关论文
共 58 条
[31]   Involvement of the MAP kinase ERK2 in MUC1 mucin signaling [J].
Meerzaman, D ;
Shapiro, PS ;
Kim, KC .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (01) :L86-L91
[32]   MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells [J].
Mukherjee, P ;
Tinder, TL ;
Basu, GD ;
Gendler, SJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (01) :90-99
[33]  
Nagy P, 2005, CANCER RES, V65, P473
[34]   Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer [J].
Nahta, Rita ;
Yu, Dihua ;
Hung, Mien-Chie ;
Hortobagyi, Gabriel N. ;
Esteva, Francisco J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05) :269-280
[35]   Convergence of Wnt, β-catenin, and cadherin pathways [J].
Nelson, WJ ;
Nusse, R .
SCIENCE, 2004, 303 (5663) :1483-1487
[36]  
PANDEY P, 1995, CANCER RES, V55, P4000
[37]   Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (Sialomucin complex) in rat mammary gland during pregnancy [J].
Price-Schiavi, SA ;
Andrechek, E ;
Idris, N ;
Li, P ;
Rong, M ;
Zhang, J ;
Carraway, CAC ;
Muller, WJ ;
Carraway, KL .
JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 203 (01) :44-53
[38]   Rat MUC4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for Herceptin resistance [J].
Price-Schiavi, SA ;
Jepson, S ;
Li, P ;
Arango, M ;
Rudland, PS ;
Yee, L ;
Carraway, KL .
INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (06) :783-791
[39]   MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1 [J].
Rahn, JJ ;
Shen, Q ;
Mah, BK ;
Hugh, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (28) :29386-29390
[40]  
Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO